| HOME >> MEDICINE >> TECHNOLOGY |
9.4.3 Neurowave Medical Technologies' Licensing Agreement with Alaven Pharma 96
9.4.4 Cyberonics' Licensing Agreement with NeuroVista 96
9.4.5 Victhom Human Bionics' Joint Venture Agreement with Otto Bock HealthCare 96
9.4.6 Cyberonics' Agreement with Nihon Kohden 96
9.4.7 Cyberonics' Licensing Agreement with Massachusetts Institute of Technology 96
9.4.8 NeuroNexus Technologies' Research Agreement with Philips Research 96
9.4.9 Intelect Medical's Agreement with Boston Scientific 97
9.4.10 Cyberonics' Licensing Agreement with Southern Illinois University 97
9.4.11 Cyberonics' Licensing Agreement with Ethicon Endo-Surgery 97
9.4.12 Innovative Neurotronics' Agreement with Teijin Pharma 97
10 Appendix 98
10.1 Definitions 98
10.1.1 Neurostimulation Devices 98
10.1.2 Prevalence or Diseased Population 98
10.2 Sources 98
10.3 Acronyms 99
10.4 Research Methodology 101
10.4.1 Secondary Research 101
10.4.2 Primary Research 101
10.4.3 Models 102
10.4.4 Forecasts 102
10.4.5 Expert Panels 102
10.5 Contact Us 102
10.6 Disclaimer 103
List of Tables
1.1 List of Tables
Table 1: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 14
Table 2: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 16
Table 3: Neurostimulation Devices Market, Global, Key Company Revenue ($m), 2010 17
Table 4: Neurostimulation Devices Market, Global, Private Equity and Venture Capital Deals, 2011-2012 19
Table 5: Neurostimulation Devices Market, Global, Product Approvals, 2011 21
Table 6: Neurostimulation Devices Market, Global, Product Recalls, 2010-2012 22
Table 7: Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
Table 8: Spinal Cord Stimulators Market, Global, Revenu
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |